The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Amgen; Celgene; Janssen
Consulting or Advisory Role - Amgen; Celgene; Janssen

A randomized, double-blind, placebo-controlled, phase 3 study of rituximab with or without ibrutinib for Waldenstrom’s macroglobulinemia (PCYC-1127-CA).
 
Meletios A. Dimopoulos
Honoraria - Celgene; Janssen-Cilag; Onyx
Consulting or Advisory Role - Celgene; Janssen; Onyx; Pharmacyclics
Research Funding - Genesis Pharmaceuticals; Janssen
Travel, Accommodations, Expenses - Celgene; Genesis Pharmaceuticals; Onyx
 
Xavier Leleu
Honoraria - Janssen
Consulting or Advisory Role - Janssen
Travel, Accommodations, Expenses - Janssen
 
Jeffrey Matous
Consulting or Advisory Role - Celgene; Millennium
Speakers' Bureau - Celgene; Millennium; Onyx; Seagen
Research Funding - Celgene (Inst)
 
David MacDonald
Honoraria - Celgene; Lundbeck; Roche Pharma AG
Consulting or Advisory Role - Celgene; Lundbeck; Roche Pharma AG
Research Funding - Lundbeck; Roche Pharma AG
 
Judith Trotman
Research Funding - Celgene
Travel, Accommodations, Expenses - Roche Pharma AG
 
Albert Oriol
Consulting or Advisory Role - Celgene; Janssen
Expert Testimony - Celgene; Janssen
 
Chaim Shustik
No Relationships to Disclose
 
Alessandra Tedeschi
No Relationships to Disclose
 
Ramon Garcia-Sanz
Honoraria - Amgen; Janssen; Novartis; Pharmacyclics; Takeda
Consulting or Advisory Role - Amgen; Takeda
Research Funding - Novartis; Takeda
Travel, Accommodations, Expenses - Janssen
 
Leonard T. Heffner
Honoraria - Amgen
Research Funding - Amgen; Biotest; Gilead Sciences; Onyx; Pfizer; Pharmacyclics; Spectrum Pharmaceuticals
 
Shuo Ma
Consulting or Advisory Role - Abbvie; Genentech; Gilead Sciences; Pharmacyclics
Speakers' Bureau - Genentech; Gilead Sciences; Pharmacyclics
Research Funding - GlaxoSmithKline; NCCN
 
Beatrice Mahe
No Relationships to Disclose
 
Constantine Tam
Research Funding - Infinity Pharmaceuticals; Pharmacyclics; Roche Pharma AG
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Gilead Sciences
 
Olivier Tournilhac
Consulting or Advisory Role - Janssen
Research Funding - Amgen; GlaxoSmithKline; Mundipharma
Travel, Accommodations, Expenses - GlaxoSmithKline; Mundipharma; Roche Pharma AG; Sanofi
 
Jianling Li
Employment - Pharmacyclics
 
Priyanka Singh
Employment - Pharmacyclics
 
Elizabeth Bilotti
Employment - Pharmacyclics
 
Thorsten Graef
Employment - Pharmacyclics
Stock and Other Ownership Interests - Pharmacyclics
 
Steven P. Treon
Honoraria - Janssen; Pharmacyclics
Consulting or Advisory Role - Janssen; Onyx; Pharmacyclics
Research Funding - Janssen; Onyx; Pharmacyclics
Patents, Royalties, Other Intellectual Property - Dana-Farber Cancer Institute
 
Christian Buske
Consulting or Advisory Role - Gilead Sciences; Janssen; Pfizer; Roche Pharma AG
Speakers' Bureau - Gilead Sciences; Janssen; Pfizer; Roche Pharma AG
Research Funding - Janssen; Roche Pharma AG